ABSTRACT
Introduction Medical pluralism, or concurrent utilization of multiple therapeutic modalities, is common in various international contexts, and has been characterized as a factor contributing to poor health outcomes in low-resource settings. Traditional healers are ubiquitous providers in most regions, including the study site of southwestern Uganda. It is not well understood why patients in pluralistic settings continue to engage with both therapeutic healthcare modalities, rather than simply selecting one or the other. The goal of this study was to identify factors that motivate pluralistic healthcare utilization, and create a general, conceptual framework of pluralistic health behavior.
Methods In-depth interviews were conducted between September 2017 and February 2018 with patients seeking care at traditional healers (N=30) and at an outpatient medicine clinic (N=30) in Mbarara, Uganda; the study is nested within a longitudinal project examining HIV testing engagement among traditional healer-utilizing communities. Inclusion criteria included age ≥18 years, and ability to provide informed consent. Participants were recruited from healer practices representing the range of healer specialties. Following an inductive approach, interview transcripts were reviewed and coded to identify conceptual categories explaining healthcare utilization.
Results We identified three broad categories relevant to healthcare utilization among study participants: 1) traditional healers treat patients with “care”; 2) biomedicine uses “modern” technologies; and 3) peer “testimony” influences healthcare engagement. These categories describe variables at the healthcare provider, healthcare system, and peer levels that interrelate to motivate individual engagement in pluralistic health resources.
Conclusions Patients perceive clear advantages and disadvantages to biomedical and traditional care in medically pluralistic settings. We identified factors at the healthcare provider, healthcare system, and peer levels which influence patients’ therapeutic itineraries. Our findings provide a basis to improve health outcomes in medically pluralistic settings, and underscore the importance of recognizing traditional healers as important stakeholders in community health.
STRENGTHS AND LIMITATIONS OF THIS STUDY
Medical pluralism is common in both high- and low-resource settings, and has been characterized as a factor leading to poor health outcomes for both infectious and non-communicable diseases
This study identifies factors that motivate utilization of healthcare in a medically pluralistic community
Patients in pluralistic settings perceive clear advantages and disadvantages of both traditional care and biomedicine; characteristics of healthcare providers, the healthcare system, and peer influences motivate patients to engage with particular healthcare modalities
Patients often prefer traditional healing instead of biomedicine; this utilization is not simply a function of limited access to biomedical resources
Traditional healers should be considered important stakeholders in community health
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Institutes of Health (K23 MH111409), PI: Sundararajan. RK is supported by the National Institutes of Health (R01 MH109337). The study funder did not have any role in the study design, collection, analysis, interpretation of data, nor in the decision to submit the article for publication. All authors are independent from the funders, and had full access to all of the data. All authors take responsibility for the integrity of the data and accuracy of the data analysis.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
Deidentified data may be shared upon reasonable request by emailing the first author.